NanoViricides, Inc. NNVC
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -0.20% | -23.02% | 23.46% | -34.92% | -22.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.18% | -9.74% | 8.46% | -43.28% | -11.53% |
| Operating Income | -6.18% | 9.74% | -8.46% | 43.28% | 11.53% |
| Income Before Tax | -6.08% | 10.26% | -9.53% | 42.91% | 11.04% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.08% | 10.26% | -9.53% | 42.91% | 11.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.08% | 10.26% | -9.53% | 42.91% | 11.04% |
| EBIT | -6.18% | 9.74% | -8.46% | 43.28% | 11.53% |
| EBITDA | -8.29% | 7.65% | -12.71% | 44.02% | 11.19% |
| EPS Basic | 22.86% | 33.41% | 19.55% | 54.17% | 32.73% |
| Normalized Basic EPS | 22.96% | 33.53% | 19.66% | 54.18% | 32.67% |
| EPS Diluted | 22.86% | 33.41% | 19.55% | 54.17% | 32.73% |
| Normalized Diluted EPS | 22.96% | 33.53% | 19.66% | 54.18% | 32.67% |
| Average Basic Shares Outstanding | 37.54% | 34.84% | 36.22% | 24.54% | 32.19% |
| Average Diluted Shares Outstanding | 37.54% | 34.84% | 36.22% | 24.54% | 32.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |